Subscribe: WSJ.com: Health
http://online.wsj.com/xml/rss/3_7089.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
act  administration  affordable care  affordable  care act  care  company  drug  health care  health  law  new  patients  theranos 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: WSJ.com: Health

WSJ.com: Health



Health



Last Build Date: Sat, 10 Dec 2016 00:30:37 EST

Copyright: copyright © 2016 Dow Jones & Company, Inc.
 



Bayer Teams Up With Versant to Develop Stem-Cell Therapies

Fri, 09 Dec 2016 20:10:54 EST

Bayer and U.S. healthcare investor Versant Ventures plan to establish a stem-cell research company called BlueRock Therapeutics, with initial joint funding of $225 million.



In Antitrust Trial, Justice Department Questions Aetna-Humana Asset Sale Plan

Fri, 09 Dec 2016 13:33:02 EST

The Justice Department hammered away in court at the viability of a plan by Aetna Inc. and Humana Inc. to sell off assets in order to alleviate antitrust concerns about their proposed $34 billion merger.



Horizon Pharma Shares Plunge on Failed Late-Stage Study

Thu, 08 Dec 2016 11:39:52 EST

Horizon Pharma shares slid 20% after a late-stage study for a genetic disease treatment broadly failed testing.



Endo Sells Back Rights for Opioid Painkiller

Thu, 08 Dec 2016 09:51:52 EST

Endo International said it had sold back the rights to an opioid pain drug to BioDelivery Sciences International as the market for opioid-based painkillers has come under fire.



Former Insys CEO Arrested in Opioid Prescription Kickback Case

Fri, 09 Dec 2016 13:57:43 EST

Six former executives and managers at Insys Therapeutics were arrested and charged with conspiring to defraud health insurers and bribe doctors in exchange for prescribing the company’s fentanyl painkiller, Subsys.



Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug

Wed, 07 Dec 2016 14:41:52 EST

Pfizer has become the latest drugmaker taken to task for high prices after U.K. authorities hit the company with a record $107 million fine over the price of an anti-epilepsy drug.



Senate Clears Bill to Ease FDA Drug and Device Approvals

Wed, 07 Dec 2016 22:39:17 EST

The Senate approved legislation aimed at speeding up Food and Drug Administration approvals, which is expected to usher in a new, more industry-friendly era of drug and device regulation.



Women Face 20% Higher Health-Care Costs in Retirement, Survey Finds

Wed, 07 Dec 2016 04:35:31 EST

When it comes to saving for health-care costs in retirement, women need to set aside more—almost 20% more, on average—to cover their medical bills in the final years of their lives, according to a survey released Wednesday.



New York Expands Transgender Health Care

Tue, 06 Dec 2016 20:17:27 EST

Medicaid in New York will begin covering gender-transition care for youths under a state regulation that goes into effect Wednesday, health department officials said.



In a Test, Cancer Hospital Customizes Diet to Help Patients

Tue, 06 Dec 2016 21:45:52 EST

An innovative program at NYU Langone is tackling a big problem that keeps many cancer patients from healing—loss of appetite.



Mumps Outbreaks Are Worst in a Decade

Tue, 06 Dec 2016 15:10:45 EST

The number of mumps cases has nearly tripled in 2016, making it the worst year for outbreaks in a decade. Despite widespread vaccination requirements, college campuses are bearing the brunt of the attack.



Theranos Predicted Huge Growth in Revenue and Profits

Tue, 06 Dec 2016 13:45:34 EST

Investor materials show the blood-testing company projected revenue of nearly $2 billion and net income of about $505 million this year.



Senate Clears Path for Bill to Speed FDA Drug Approvals

Mon, 05 Dec 2016 19:13:32 EST

The Senate Monday cleared the final hurdle to passage of broad legislation aimed at boosting federal funds for biomedical research and speeding up government approval of drug and medical-devices.



Aetna and Humana Defend Merger, as Antitrust Trial Begins

Mon, 05 Dec 2016 21:36:00 EST

The Justice Department and proposed merger partners Aetna Inc. and Humana Inc. presented a judge Monday with starkly different visions of how the transaction would affect the marketplace.



Nerve Treatment When Drugs Fail

Mon, 05 Dec 2016 12:32:09 EST

To help migraines, rheumatoid arthritis and other conditions, scientists try stimulating the vagus nerve, the same part of the nervous system activated by breathing exercise during meditation.



Bloomberg Expands Effort to Curb Tobacco Use World-wide

Mon, 05 Dec 2016 12:35:35 EST

Former New York City mayor and billionaire philanthropist Michael Bloomberg has spent hundreds of millions of dollars of his fortune over the past decade fighting tobacco use in the developing world. Now, with cigarette use declining globally, he is deepening his campaign.



Crossing State Lines Is No Easy Jaunt for Insurers, Local Regulators

Mon, 05 Dec 2016 22:16:15 EST

As Republicans gear up to overhaul the federal health law, they face pushback from a couple unexpected corners on one of their goals: Giving health insurers greater ability to sell policies to consumers across state lines.



FDA Presses Hospitals on Medical-Device Problems

Fri, 02 Dec 2016 19:53:32 EST

The U.S. Food and Drug Administration is pushing hospitals to do a better job reporting medical-device problems after finding many lapses, including failures to flag a hysterectomy device’s potentially deadly risk.



Valeant's Discussions to Sell Salix to Takeda Have Broken Down

Thu, 01 Dec 2016 01:22:54 EST

Valeant’s talks to sell a stomach-drug business to Japan’s Takeda Pharmaceutical for roughly $10 billion have broken down.



House Passes Bill to Speed Drug Approvals, Boost Medical Research

Thu, 01 Dec 2016 00:28:13 EST

The House passed far-reaching legislation aimed at bolstering federal funds for biomedical research and speeding up drug and medical-device approvals, a goal long sought by the pharmaceutical industry.



Getting a New Health Law Through Senate Will Be a Test

Wed, 30 Nov 2016 16:32:52 EST

Republicans on Capitol Hill are grappling with the likelihood that they will need Democratic support to pass parts of any plan replacing the Affordable Care Act, setting up a complex legislative battle over the law’s future.



DEA Bans a Cousin of Deadly Synthetic Opioid Fentanyl

Wed, 30 Nov 2016 14:50:02 EST

The Drug Enforcement Administration added furanyl fentanyl, a deadly cousin of the synthetic opioid fentanyl, to its most restrictive list of controlled substances.



Sanofi Drug-Development Partnership Passes First Test

Tue, 29 Nov 2016 21:54:09 EST

Sanofi SA has received its first set of drug compounds from its collaboration with a Harvard University scientist and his venture backers that aims to jumpstart discovery of new medicines.



Anthem Begins Defense of Cigna Merger at Antitrust Trial

Wed, 30 Nov 2016 09:45:29 EST

Anthem Inc. executives told a judge that consumers would benefit from the company’s proposed acquisition of Cigna Corp., saying the new company would be innovative while not reducing competition in the marketplace.



Trump Signals Big Health Policy Changes Are Coming

Tue, 29 Nov 2016 23:16:28 EST

In tapping Rep. Tom Price and Medicaid consultant Seema Verma for top health positions, President-elect Donald Trump is signaling that he intends to put conservative health-policy goals at the forefront of his administration.



Novo's New Insulin Reduces Risk of Low Blood Sugar, Study Shows

Tue, 29 Nov 2016 19:22:25 EST

Novo Nordisk said its new insulin Tresiba carries about the same risk of serious heart problems as Sanofi’s Lantus but offers significantly lower risk of dangerously low blood sugar in people with Type-2 diabetes.



Big Names Take Hit on Theranos

Tue, 29 Nov 2016 10:26:53 EST

Blood-testing company got much of its funding from high-profile private investors who weren’t part of the ecosystem that typically backs startups and could see their stakes wiped out.



Theranos Sued for Alleged Fraud by Robertson Stephens Co-Founder Colman

Mon, 28 Nov 2016 19:06:05 EST

Robertson Stephens & Co. co-founder Robert Colman accused Theranos Inc. in a lawsuit filed Monday of making false and misleading claims about its operations and technology while soliciting money from investors.



UnitedHealth Gives Upbeat Outlook for 2017

Mon, 28 Nov 2016 17:37:14 EST

UnitedHealth Group on Monday preannounced guidance for next year that topped expectations ahead of the health insurer’s annual investor conference.



Marlboro Black Lures Back Millennial Smokers

Mon, 28 Nov 2016 22:03:02 EST

A slide in the share of young adult smokers who choose Marlboro cigarettes has been arrested by Philip Morris’s introduction of a lower-priced alternative to its traditional Reds.



Drugmakers Find Competition Doesn't Keep a Lid on Prices

Sun, 27 Nov 2016 21:30:10 EST

Pfizer and Eli Lilly have raised the price of their erectile-dysfunction drugs Viagra and Cialis almost in lockstep over the past few years, a common practice in the pharmaceutical industry.



Can't Get to Sleep? Lay Off the Drugs

Mon, 28 Nov 2016 11:19:46 EST

Doctors are steering patients to solutions other than sleep aids



Playgrounds for an Aging Population

Sun, 27 Nov 2016 22:35:39 EST

The idea: Outdoor exercise is good for older adults both physically and mentally.



J&J Approaches Swiss Firm Actelion About Potential Deal

Sat, 26 Nov 2016 10:52:13 EST

Johnson & Johnson has approached Swiss biopharmaceutical company Actelion about a possible deal, the two companies said Friday.



Eli Lilly Alzheimer's Drug Fails Trial; Shares Plunge

Thu, 24 Nov 2016 04:37:22 EST

An experimental Eli Lilly drug failed to significantly help Alzheimer’s disease patients in a closely watched clinical trial, dealing another blow to the pharmaceutical industry’s long quest to find a better treatment for the brain-damaging condition.



Fentanyl Billionaire Under Fire as Opioid Death Toll Mounts

Wed, 23 Nov 2016 09:45:49 EST

Just a handful of doctors, many with close ties to Insys Therapeutics, co-founded by John N. Kapoor, are responsible for outsize levels of prescribing of Subsys, a form of the powerful opioid fentanyl, according to a Wall Street Journal analysis. Federal and state prosecutors and regulators in more than 15 jurisdictions are investigating the company’s business practices.



Some Zika-Caused Defects Show Up Well After Birth

Wed, 23 Nov 2016 20:30:51 EST

More than a year after doctors in Brazil first suspected the Zika virus was behind a wave of babies born with deforming birth defects, a new realization is coming into focus: Even babies appearing normal at birth aren’t necessarily out of the woods.



Alaska's Novel Plan to Cut Health Premium Costs

Tue, 22 Nov 2016 21:01:04 EST

Health-insurance premiums for Alaskans have been soaring almost 40% a year. That prompted the state government to make a novel move: to pay health costs for about 500 of the sickest residents to hold down premiums for everyone else.



House Republicans Ask to Put on Hold Case Against Obama's Health-Care Law

Tue, 22 Nov 2016 14:44:40 EST

Attorneys for the U.S. House of Representatives asked a federal court to delay a lawsuit over President Barack Obama’s signature health-care law, citing negotiations with President-elect Donald Trump over the future of the Affordable Care Act.



Slow Start for Soda Makers' Push to Cut Calories

Wed, 23 Nov 2016 13:14:01 EST

U.S. beverage calories per person declined only 0.2% in 2015, a slower rate of decrease than in earlier years, despite efforts by the likes of Coke and Pepsi to cut such calories in the American diet by 20% over a decade.



Brewers Bet Beer Drinkers Seek More Sober Suds

Tue, 22 Nov 2016 12:27:31 EST

After years of trying and failing to jump-start sales of alcohol-free beer, brewers like AB InBev, Heineken and Carlsberg are expanding their nonalcoholic offerings with renewed zeal.



Uncertain Times for Health Insurer Started by Kushner's Brother

Mon, 21 Nov 2016 23:00:16 EST

For health insurance startup Oscar Insurance, the election of Donald Trump could be a tough pill to swallow, complicated by ownership ties to the incoming administration that will put it under a bright spotlight.



Anorexic Woman Can Refuse Force-Feedings, Court Rules

Mon, 21 Nov 2016 20:33:39 EST

An anorexic woman who weighs 69 pounds can refuse force-feedings, a New Jersey superior court judge ruled. The woman told the court that she doesn’t want food or water and wants to enter palliative care.



Anthem to Defend Cigna Deal in Court

Mon, 21 Nov 2016 08:07:49 EST

The trial starts Monday in the Justice Department’s challenge to health insurer Anthem’s $48 billion acquisition of reluctant partner Cigna, a case that could produce unusual courtroom drama.



Theranos Whistleblower Shook the Company---and His Family

Fri, 18 Nov 2016 11:17:26 EST

Tyler Shultz says he wanted to shield the reputation of former Secretary of State George Shultz, a Theranos director and his grandfather. His efforts opened a family rift.



Report Warns of Alcohol-Related Cancer Deaths in England

Thu, 17 Nov 2016 23:08:13 EST

England could suffer 135,000 cancer deaths caused by alcohol consumption over the next two decades should current drinking trends continue, according to a new report.



Sign-Ups Under Affordable Care Act So Far Seem Not Hurt by Trump Win

Wed, 16 Nov 2016 18:26:27 EST

More than a million people chose plans on the federal exchange in the first two weeks of open enrollment under the Affordable Care Act, indicating sign-ups haven’t been hurt by Donald Trump’s plans to repeal or amend the law.



Patients May Still Get a 'Surprise' Bill After an In-Network ER Visit

Thu, 17 Nov 2016 10:24:33 EST

Patients who get emergency care at a hospital in their insurance network have nearly a 1 in 4 chance of being treated by an out-of-network ER physician who may send a “surprise” bill, according to an analysis in the New England Journal of Medicine.



One Employer Fights Against Prescription-Drug Abuse

Tue, 15 Nov 2016 22:20:41 EST

After managers found evidence of drug activity in one of its plants in 2013, engine-maker Cummins has made it harder for employees to obtain prescriptions for potentially addictive painkillers.



Suit Says Glaxo's Conduct Led to Couple's Imprisonment in China

Wed, 16 Nov 2016 11:28:19 EST

Two former corporate investigators sued GlaxoSmithKline on Tuesday, alleging that the drugmaker hired them under false pretenses that led the pair to be imprisoned in China.



Walgreens Claims Theranos Voided 11.3% of Test Reports

Wed, 16 Nov 2016 16:22:23 EST

Theranos allegedly voided 11.3% of all blood-test reports that the Silicon Valley laboratory firm provided to Walgreens customers during a yearslong partnership between the companies, said a court filing by the drug chain.



On GOP Path to Health-Law Repeal, Questions Emerge

Tue, 15 Nov 2016 18:30:07 EST

Republicans who have put a repeal of the Affordable Care Act at the top of their to-do list face a set of early, key decisions that will test the party’s consensus on the issue.



Study Suggests Heart Patients May Need Fewer Blood Thinners

Mon, 14 Nov 2016 21:01:02 EST

Researchers said a study involving reduced doses of Johnson & Johnson’s anticoagulant Xarelto suggests it may be possible for patients with two types of heart disease to avoid the need for three different blood thinners to protect them from stroke and heart attack.



Medicare Identifies Which Prescription Drugs Were Costliest in 2015

Mon, 14 Nov 2016 21:24:56 EST

Medicare released new data identifying prescription medicines that had sharp price increases and those which accounted for its largest total spending in 2015.



West Nile Virus Results in More Deaths Than Expected

Mon, 14 Nov 2016 20:41:32 EST

West Nile virus may be deadlier than public health officials and doctors have thought, according to researchers in Texas who examined more than 4,100 cases in their state.



Study Suggests Celebrex Isn't Riskier Than Rival Pain Drugs

Mon, 14 Nov 2016 10:43:53 EST

A major study of drugs used to treat arthritis pain challenges some long-held assumptions about the safety of pills taken by millions of patients world-wide.



Interview: Trump Willing to Keep Parts of Health Law

Sun, 13 Nov 2016 09:29:47 EST

President-elect Donald Trump, in an exclusive interview, said that after meeting with President Obama he would consider leaving in place certain parts of the Affordable Care Act, an indication of possible compromise after he pledged repeatedly to repeal the health law.



Affordable Care Act Enrollment Surges Following Trump Election

Fri, 11 Nov 2016 14:23:52 EST

The government reported a surge in people picking plans on the Affordable Care Act’s federal exchange on the day after voters elected a presidential candidate who has pledged to repeal the law.



Mylan Posts Loss, Hurt by Lower EpiPen Volumes, Charge Related to Settlement

Thu, 10 Nov 2016 09:42:54 EST

Mylan swung to a quarterly loss as it booked a big charge related to a settlement with authorities on contentious pricing of its EpiPen, and revenue growth came in below expectations as volumes of the lifesaving auto-injector fell.



Walgreen Sues Theranos, Seeking to Recover $140 Million

Wed, 09 Nov 2016 10:50:45 EST

Drugstore giant Walgreen Co. has sued its former lab-testing partner Theranos Inc. in federal court in Delaware, alleging it breached a contract between the two companies.



Valeant Stock Slides After Profit Forecast Is Chopped

Tue, 08 Nov 2016 18:01:00 EST

Valeant returned to slashing its annual outlook, signaling the pharmaceutical company is still hemorrhaging from missteps over the past year and indicating it may take longer than expected to remake its business.



CVS Warns of Prescriptions Shift, Shares Tumble

Tue, 08 Nov 2016 21:55:29 EST

CVS Health warned that it stands to lose 40 million prescriptions next year as deals signed by rival Walgreens Boots Alliance with other participants in the drug supply chain shut out CVS stores.



Senate Panel Urges FTC to Review Mylan

Tue, 08 Nov 2016 09:33:24 EST

Lawmakers continued criticizing Mylan over its EpiPen injector, with two leaders of the Senate Judiciary Committee calling for the Federal Trade Commission to review whether Mylan engaged in anti-competitive practices.



UPS Acquires Marken to Focus More on Medical Deliveries

Tue, 08 Nov 2016 12:10:27 EST

United Parcel Service Inc. said Monday it agreed to acquire clinical logistics company Marken Ltd., deepening its push into the profitable business of medical deliveries.



Demand for Nurses Rises, Pushing Up Wages, Bonuses

Mon, 07 Nov 2016 21:13:03 EST

After years of relative equilibrium, the job market for nurses is heating up in many markets, driving up wages and sign-on bonuses for the nation’s fifth-largest occupation.



Worst-Performing Stocks of 2016: Health Care

Sun, 06 Nov 2016 22:29:18 EST

For health-care stocks, this year’s worst-performing sector in the S&P 500, any outcome in Tuesday’s U.S. elections might prove cathartic.



Valeant, Pushing to Pare Debt, Weighs Sale of Eye-Surgery Unit

Wed, 02 Nov 2016 22:23:52 EDT

Valeant is exploring a sale of its eye-surgery-equipment business as part of a sweeping effort to unload assets and pare debt.



Japan's Takeda Seeks to Expand Overseas

Wed, 02 Nov 2016 22:26:25 EDT

A potential $10 billion deal to buy Valeant’s Salix business shows how Japan’s largest drugmaker by sales is betting on the U.S. and Europe for growth.



Community Health Systems Expanding Sale of Hospitals

Wed, 02 Nov 2016 18:46:39 EDT

Distressed hospital operator Community Health Systems, Inc. announced it put more hospitals up for sale to raise cash and pay down debt, as its faltering turnaround drags on.



Health Law Enrollment Opens Amid Volatility

Tue, 01 Nov 2016 21:32:00 EDT

The fourth open enrollment for health coverage under the Affordable Care Act opened Tuesday, a critical 90 days that the Obama administration hopes will boost participation and stabilize markets roiled by premium increases and insurer withdrawals.



Companies Give Workers a Cut of Health Savings

Tue, 01 Nov 2016 10:01:19 EDT

A growing number of employers are using new tools that allow workers to compare prices for common procedures like MRIs and blood work, and get rewarded if they opt for lower-cost health-care options.



Trump Shifts Attacks to Obamacare, Health-Care Costs

Tue, 01 Nov 2016 21:46:55 EDT

Donald Trump turned from attacking Hillary Clinton over her emails to focusing on voters’ pocketbook issues, denouncing President Barack Obama’s health-care law and the recent rise in individual insurance premiums.



Inside the Affordable Care Act's Arizona Meltdown

Tue, 01 Nov 2016 08:38:27 EDT

Nearly every county in the state now has only one insurer selling plans through the health-care law’s exchange, and premiums are soaring.



Cardinal Health Warns Over Drug Pricing

Mon, 31 Oct 2016 17:15:36 EDT

Cardinal Health became the latest drug distributor to warn that the slowing pace of branded drug-price increases and lower generic drug pricing would hurt results.



Boy's Death Led to Misuse of Genetic Test, Study Says

Mon, 31 Oct 2016 00:01:04 EDT

A 13-year-old boy’s sudden cardiac death led doctors to wrongly diagnose more than 20 of his relatives with a potentially lethal heart disorder in a case that illustrates the potential for genetic testing to go wrong.



Blackstone to Acquire Team Health for About $3.2 Billion

Mon, 31 Oct 2016 17:55:16 EDT

Team Health Holdings said Monday the company has reached a deal to sell itself to a group of investors led by private-equity firm Blackstone Group for about $3.2 billion.



Drugmakers Turn Cheap Generics Into Expensive Pills

Mon, 31 Oct 2016 10:21:34 EDT

Treximet, a migraine drug, is just one of many treatments whose active ingredients are generic drugs that can be purchased separately at a fraction of the cost.



Aetna Revenue and Profit Rise

Thu, 27 Oct 2016 13:11:50 EDT

Aetna said revenue and profit rose in its latest quarter, but the insurer is still struggling with pressure in the Affordable Care Act business, which it will largely exit next year.



Where the Elderly Die Can Vary by Region, Study Shows

Wed, 26 Oct 2016 17:00:05 EDT

How much time people spend in hospitals or nursing homes in the final months of life, instead of at home, varies widely depending on where they live, new research shows.



Silicon Valley Puzzled Over Regulators' Views on Health Technologies, 23andMe CEO Says

Sun, 30 Oct 2016 17:52:13 EDT

Genetic-testing company 23andMe CEO Anne Wojcicki said there is a disconnect between Silicon Valley and the U.S. regulatory system over how to view new health-related technologies.



Community Health Projects Third-Quarter Loss

Wed, 26 Oct 2016 20:30:03 EDT

Hospital operator Community Health Systems said Wednesday it would post a third-quarter loss as it recorded a 10% drop in operating revenue and further reduced the value of its hospitals.



If Monsanto Loses Its Name, What Will Its Haters Have Left to Hate?

Tue, 25 Oct 2016 17:22:21 EDT

Bayer’s $57 billion offer for Monsanto—aka “Monsatan”—means GMO protesters must rethink familiar old slogans and insults, and compose new songs for a company that has long been a target for activists.



Edwards Lifesciences Shares Fall After-Hours

Tue, 25 Oct 2016 19:42:37 EDT

Shares of Edwards Lifesciences fell sharply in after-hours trading Tuesday after the medical-device maker reported lower-than-expected sales of its minimally-invasive heart valves in the third quarter.



Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment

Tue, 25 Oct 2016 11:54:21 EDT

Merck & Co.’s immunotherapy cancer drug Keytruda received U.S. Food and Drug Administration approval as a first-line treatment for certain lung cancer patients.



Catholic Health Initiatives, Dignity Health in Merger Talks

Mon, 24 Oct 2016 18:25:39 EDT

Hospital operator Catholic Health Initiatives, which has struggled after rapid expansion and a foray into health insurance, is in merger talks with Dignity Health to create one of the nation’s largest nonprofit hospital systems by revenue.



ACA Cites Later Deadlines for Those Who Lost Their Health Plans

Tue, 25 Oct 2016 16:28:38 EDT

The Obama administration confirmed a 25% average jump in premiums for the Affordable Care Act’s benchmark health plan. It also acknowledged an extension of the sign-up deadline for hundreds of thousands of people.



Faith-Based Investor Group Calls for Transparency in Drug Pricing

Mon, 24 Oct 2016 21:42:35 EDT

A group of 300 institutional investors, including many with ties to religious organizations, is waging a new campaign to press drugmakers to justify their price increases.



Rising Insurance Premiums Boost Talk of Changes to Affordable Care Act

Fri, 21 Oct 2016 14:49:50 EDT

Insurer defections and rising premiums in the individual insurance market are spurring Democrats and Republicans alike to talk about changes to the 2010 Affordable Care Act.



National Cancer Institute Researchers Didn't Quickly Tell FDA of Two Deaths

Fri, 21 Oct 2016 13:54:02 EDT

The National Cancer Institute has concluded that some of its lymphoma researchers failed to notify the Food and Drug Administration in a timely fashion about fungal infections that resulted in two deaths of patients in one of its research studies.



Cigna Ends Preauthorization for Medication to Treat Opioid Addiction

Fri, 21 Oct 2016 14:51:13 EDT

Cigna Corp. will stop requiring that patients and doctors jump through extra hoops known as prior authorization to receive coverage of a medication to treat opioid addiction under a settlement with New York State’s Attorney General.



Agony, Alarm and Anger for People Hurt by Theranos's Botched Blood Tests

Fri, 21 Oct 2016 09:51:03 EDT

Questionable results led to changes in medical treatment. Weeks or months passed before Theranos told many people their results were unreliable.



Obama Defends Health-Care Law

Thu, 20 Oct 2016 17:40:48 EDT

President Barack Obama defended his signature health-care act in a speech that described his pride in the achievements of the law and acknowledged significant challenges his successor will face.



Whole Foods in Detroit Is Probed Amid Link to Hepatitis A

Fri, 21 Oct 2016 09:50:00 EDT

Health officials in Detroit have opened an investigation into a local Whole Foods Market store over fears that two recently diagnosed cases of hepatitis A may be linked to the grocer’s prepared-foods section.



Lawsuit Over Cellphones and Cancer Hits a Stumbling Block

Thu, 20 Oct 2016 15:49:30 EDT

An appeals court dealt a setback to a long-running lawsuit against the wireless industry over health concerns surrounding cellphones, deciding that a different legal standard for evidence should have been applied.



Abbott Labs Swings to Loss After Booking Charge on Mylan Stake

Wed, 19 Oct 2016 20:16:46 EDT

Abbott Laboratories swung to a loss in the most recent quarter as it booked a hefty charge related to the stock-price drop of embattled EpiPen maker Mylan NV, in which it owns a stake.



Obama Administration Expects Robust ACA Open Enrollment

Wed, 19 Oct 2016 20:52:39 EDT

The Obama administration said Wednesday it expects 13.8 million people to select a health plan on the Affordable Care Act’s exchanges by the end of the coming open enrollment for 2017 coverage, an optimistic goal.



Medicare Spent $359 Million on Unnecessary Chiropractic Care

Wed, 19 Oct 2016 06:23:32 EDT

More than 80% of the money that Medicare paid to chiropractors in 2013 went for medically unnecessary procedures, a new federal audit found.



Rate Increases for Health Plans Pose Serious Test for Obama's Signature Law

Tue, 18 Oct 2016 23:41:02 EDT

Finalized rates for big health insurance plans show the magnitude of the challenge facing the Obama administration as it seeks to stabilize the insurance market under the Affordable Care Act in its remaining weeks in office.



J&J Brushes Off Looming Biosimilar Competition

Tue, 18 Oct 2016 15:23:28 EDT

Johnson & Johnson sought to reassure investors and analysts that lower-priced competition for one of its top-selling products won’t slow a company that posted slightly better-than-expected results in the third quarter.